Growth fraction determination in pulmonary hypoplasia using Ki-67 (MIB-1) antibody

Fetal and Pediatric Pathology

Volumn 16, Issue 5, 1996, Pages 745-754

  Thomas, P A ^a   Durbin, J ^b   Langston, C ^c   Raab, S S ^a   Jagirdar, J ^b   Greco, M A ^b  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

growth fraction; immunohistochemistry; Ki 67; pulmonary hypoplasia

Indexed keywords

MONOCLONAL ANTIBODY KI 67;

ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; DEVELOPMENTAL DISORDER; FETUS; GESTATIONAL AGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG HYPOPLASIA; LUNG WEIGHT; NEWBORN; PRIORITY JOURNAL;

ABORTION, SPONTANEOUS; ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; BODY WEIGHT; BRONCHI; CELL DIVISION; EPITHELIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT, NEWBORN; KI-67 ANTIGEN; LUNG; ORGAN SIZE; PREGNANCY; PULMONARY ALVEOLI;

EID: 85047686862     PISSN: 15513815     EISSN: 15513823     Source Type: Journal    
DOI: 10.1080/713601220     Document Type: Article

References (22)

1. Kitagawa M, Hislop A, Boyden EA, Reid L. Lung hypoplasia in congenital diaphragmatic hernia: A quantitative study of ainuay, artery, and alveolar development. UrJ Surg 197 I ;58:342-6.
2. Click PL, Stannard VA, Leach CL, et al. Pathophysiology of congenital diaphragmatic hcrnia 11: The fetal lamb CDH model is surfactant deficient. J Pediatr Surg 1992;27:382-8.
3. Nakamura Y, Haracla K, Yamamoto I, et al. Human pulmonary hypoplasia: Statistical, morphological, morphometric, and biochemical study. Arch Pathol Lab Med 1992;116:635-42.
4. Perlman M, WilliamsJ, Hirsch M. Neonatal pulmonary hypoplasia after prolonged leakage of amniotic fluid. Arch Dis Child 1976;51:349-53.
5. Hepworth WB, Seegmiller RE, Carey JC. Thoracic volume reduction as a mechanism for pulmonary hypoplasia in chondrodystrophic mice. Pediatr Pathol 1990;10:919-29.
6. Askenazi SS, Perlman M. Pulmonary hypoplasia: Lung weight and radial alveolar count as criteria of diagnosis. Arch Dis Child 1979;54:614-18.
7. Langston C, Reed M, Thurlbeck W. Human lung growth in late gestation in the neonate. Am Rev Respir Dis 1984;129:607-13.
8. Cooney TP, Thurlbeck WM. The radial alveolar count method of Emery and Mithal: A reappraisal 1-postnatal lung growth. Thorax 1982;378:572-9.
9. Cooney TP, Thurlbeck WM. The radial alveolar count method of Emery and Mithal: A reappraisal 2-intrauterine and early postnatal lung growth. Thorax 1982;37:580-3.
10. Hislop AA, Wigglesworth JS, Desai R. Alveolar development in the human fetus and infant. Early Hum Dev 1986 13:l-11.
11. Wigglesworth JS, Desai R, Aber V. Quantitative aspects of perinatal lung growth. Early Hum Dev 1987;15:203-12.
12. Wigglesworth JS, Desai R. Use of DNA estimation for growth assessment in normal and hypoplastic fetal lungs. Arch Dis Child 1981;56:601-5.
13. Burger PC, Shibata T, Kleihues P. The use of monoclonal antibody Ki-67 in the identification of proliferating cells: Application to surgical neuropathology. Am J Surg Pathol 1986;10:611-17.
14. Bouzbar N, Walker KJ, Griffiths K, et al. Ki67 immunostaining in primaly breast cancer: Pathological and clinical associations. Br J Cancer 1989;59:943-7.
15. Isola J, Helin HJ, Helle MJ, Kallioniemi 0-P. Evaluation of cell proliferation in breast carcinoma: Comparison of Ki-67 immunohistochemical study, DNA flow cytometric analysis, and mitotic count. Cancer 1990;65:1180-4.
16. Pich A, Ponti R, Valente G, et al. MIB-I, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas. J Clin Pathol 1994;47: 18-22.
17. Hendricks JB, Wilkinson EJ. Quality control considerations for Ki-67 detection and quantitation in paraffinembedded tissue. J Cell Biochem 1994;56:105-10.
18. Moens CB, Auerbach AB, Conlon RA, Joyner AL, RossantJ. A targeted mutation reveals a role for N-my in branching morphogenesis in the embryonic mouse lung. Genes Dev 1992;6:691-704.
19. Hirning U, Schmid P, Schulz WA, Rettenberger G, Hameister H. A comparative analysis ofN-mycand c-myc expression and cellular proliferation in mouse organogenesis. Mech Dev 1991 ;33:119-26.
20. Cangiarella J, Greco MA, Askin F, Perlman E, Goswami S, Jagirdar J. Congenital cystic adenomatoid malformation of the lung. Insights into the pathogenesis utilizing quantitative analysis of vascular marker CD34 (QBEND-10) and cell proliferation marker MIB-I. Mod Pathol 1995:913-38.
21. Margraf LR, Landers S, Langston C, Reiter A, Carpenter RJ. Successful prenatal therapy of thoracic lesions. Pediatr Pathol 1993;13:613-20.
22. Thurlbeck WM, Kida K, Langston C, et al. Postnatal lung growth after repair of diaphragmatic hernia. Thorax 1979;34:338-43.